stocks logo

AVNS

Avanos Medical Inc
$
13.110
+0.360(+2.820%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
13.130
Open
12.810
VWAP
13.03
Vol
582.93K
Mkt Cap
606.26M
Low
12.680
Amount
7.60M
EV/EBITDA(TTM)
5.58
Total Shares
45.90M
EV
600.01M
EV/OCF(TTM)
4.46
P/S(TTM)
0.86
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
166.80M
-2.85%
0.190
-44.12%
165.90M
-2.64%
0.280
-22.22%
176.30M
-1.84%
0.340
-20.93%
Estimates Revision
The market is revising Downward the revenue expectations for Avanos Medical, Inc. (AVNS) for FY2025, with the revenue forecasts being adjusted by -2.74% over the past three months. During the same period, the stock price has changed by -15.58%.
Revenue Estimates for FY2025
Revise Downward
down Image
-2.74%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-18.18%
In Past 3 Month
Stock Price
Go Down
down Image
-15.58%
In Past 3 Month
2 Analyst Rating
up Image
29.67% Upside
Wall Street analysts forecast AVNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVNS is 17.00 USD with a low forecast of 17.00 USD and a high forecast of 17.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
up Image
29.67% Upside
Current: 13.110
sliders
Low
17.00
Averages
17.00
High
17.00
No Data

Valuation Metrics

The current forward P/E ratio for Avanos Medical Inc (AVNS.N) is 14.91, compared to its 5-year average forward P/E of 22.79. For a more detailed relative valuation and DCF analysis to assess Avanos Medical Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
22.79
Current PE
14.91
Overvalued PE
35.86
Undervalued PE
9.72

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
12.05
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
17.42
Undervalued EV/EBITDA
6.69

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
1.75
Current PS
0.83
Overvalued PS
2.33
Undervalued PS
1.17

Financials

Annual
Quarterly
FY2025Q1
YoY :
+0.84%
167.50M
Total Revenue
FY2025Q1
YoY :
+17.65%
12.00M
Operating Profit
FY2025Q1
YoY :
+1220.00%
6.60M
Net Income after Tax
FY2025Q1
YoY :
-800.00%
0.14
EPS - Diluted
FY2025Q1
YoY :
-257.02%
19.00M
Free Cash Flow
FY2025Q1
YoY :
-6.06%
53.61
Gross Profit Margin - %
FY2025Q1
YoY :
+743.88%
16.54
FCF Margin - %
FY2025Q1
YoY :
+1213.33%
3.94
Net Margin - %
FY2025Q1
N/A
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
106.8K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
186.4K
Volume
2
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
30.9K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
2
138.8K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

AVNS News & Events

Events Timeline

2025-05-06 (ET)
2025-05-06
07:17:34
Avanos sees FY25 adjusted EPS 75c-95c
select
2025-05-06
07:16:33
Avanos reports Q1 adjusted EPS 26c vs. 22c last year
select
2025-04-02 (ET)
2025-04-02
07:04:35
Avanos takes control over sales and distribution of MIC-KEY products in the UK
select
Sign Up For More Events

News

9.5
04-28PRnewswire
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
2.0
04-17Benzinga
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
7.5
04-02PRnewswire
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
Sign Up For More News

FAQ

arrow icon

What is Avanos Medical Inc (AVNS) stock price today?

The current price of AVNS is 13.11 USD — it has increased 2.82 % in the last trading day.

arrow icon

What is Avanos Medical Inc (AVNS)'s business?

arrow icon

What is the price predicton of AVNS Stock?

arrow icon

What is Avanos Medical Inc (AVNS)'s revenue for the last quarter?

arrow icon

What is Avanos Medical Inc (AVNS)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Avanos Medical Inc (AVNS)'s fundamentals?

arrow icon

How many employees does Avanos Medical Inc (AVNS). have?

arrow icon

What is Avanos Medical Inc (AVNS) market cap?